Physician profile
Nicholas A Scott
NPI 1588849517
$9,070.30
in general payments reported to CMS, 2019-2025
28 companies · $782 in 2025
The $782 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,294 · 2020: $895 · 2021: $896 · 2022: $1,560 · 2023: $1,034 · 2024: $1,610 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,425.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $3,295.30 | 2019-2023 | Senza |
| Abbott Laboratories | $1,847.61 | 2019-2025 | Proclaim |
| Si-Bone, INC. | $1,061.22 | 2022-2024 | |
| Biotronik Nro, INC. | $495.84 | 2024-2025 | Prospera |
| Zimmer Biomet Holdings, INC. | $328.83 | 2022 | |
| Vertiflex, INC. | $322.39 | 2019 | |
| Boston Scientific Corporation | $305.62 | 2019-2024 | |
| Medtronic, INC. | $189.15 | 2024 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Saluda Medical Americas, INC. | $188.50 | 2025 | Evoke |
| Nuvasive, INC. | $159.43 | 2022 | |
| Olympus America INC. | $131.67 | 2025 | Olympus |
| Medtronic USA, INC. | $96.40 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $88.53 | 2025 | |
| Vertos Medical, INC. | $85.92 | 2020-2023 | Mild Device Kit |
| Almatica Pharma LLC | $80.32 | 2022-2023 | Gralise |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $65.58 | 2019 | |
| Nalu Medical, INC. | $65.44 | 2021-2025 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $52.74 | 2019 | |
| Stryker Corporation | $46.85 | 2023 | Core |
| Daiichi Sankyo INC. | $43.93 | 2019 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.68 | 2025 | Relistor |
| Electronic Waveform Lab, INC. | $15.35 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.91 | 2019 | |
| Stratus Medical, LLC | $13.46 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.91 | 2020 | |
| Collegium Pharmaceutical, INC. | $12.47 | 2019 | |
| Integra Lifesciences Corporation | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.